Global X Fds genomic biotech shares owned by UBS Group
Quarter-by-quarter ownership of Global X Fds genomic biotech (GNOM) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Global X Fds genomic biotech
Tip: Access up to 7 years of quarterly data
All positions including Global X Fds genomic biotech held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Global X Fds genomic biotech by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.1M | 98k | 11.56 |
| 2023-09-30 | $969k | 95k | 10.17 |
| 2023-06-30 | $1.2M | 103k | 12.12 |
| 2023-03-31 | $1.3M | 105k | 12.32 |
| 2022-12-31 | $1.4M | 109k | 12.65 |
| 2022-09-30 | $1.7M | 139k | 12.55 |
| 2022-06-30 | $2.0M | 164k | 12.22 |
| 2022-03-31 | $6.5M | 430k | 15.03 |
| 2021-12-31 | $13M | 658k | 19.85 |
| 2021-09-30 | $16M | 713k | 22.14 |
| 2021-06-30 | $17M | 696k | 24.89 |
| 2021-03-31 | $17M | 755k | 22.48 |
| 2020-12-31 | $13M | 536k | 23.60 |
| 2020-09-30 | $7.6M | 424k | 17.98 |
| 2020-06-30 | $4.9M | 276k | 17.56 |
| 2020-03-31 | $750k | 60k | 12.45 |
| 2019-12-31 | $53k | 3.4k | 15.51 |